Laboratory diagnosis of antiphospholipid syndrome

Reumatismo

Volumn 59, Issue 3, 2007, Pages 187-191

  Pengo, Vittorio ^a   Ruffatti, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; CONSENSUS DEVELOPMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MORBIDITY; PREGNANCY COMPLICATION; THROMBOSIS; BLOOD; FEMALE; IMMUNOLOGY; MALE; PREGNANCY; RECURRENT ABORTION;

ABORTION, HABITUAL; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOSIS;

EID: 39549105225     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (26)

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
2. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-11.
3. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185-90.
4. Tincani A, Allegri F, Balestrieri G, Reber G, Sanmarco M, Meroni P, et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004; 114: 553-558.
5. Reber G, Tincani A, Sanmarco M, de Moerloose P, Boffa MC. Proposal for the measurements of anti-β2-glycoprotein I antibodies. Standardization Group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004; 2: 1860-2.
6. Galli M, Luciani D, Bertolini G, Barbui T. Lupusanticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101: 1827-32.
7. 2-Glycoprotein I, anti-prothrombin antibodies and the risk of thrombosis in the antiphospholipid sindrome. Blood 2003; 102: 2717-23.
8. Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost 2005; 93: 1147-52.
9. 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 2005; 105 (4): 1540-5.
10. Tripodi A, Biasiolo A, Chantarangkul V, Pengo V. Lupus Anticoagulant (LA) testing: performance of clinical laboratories assessed by a national survey using lyophilized affinity-purified immunoglobulin with LA activity. Clinical Chemistry 2003; 49: 1608-14.
11. Pengo V, Biasiolo A, Gresele P, Marongiu F, Erba N, Veschi F, et al. A Survey on lupus anticoagulant diagnosis by central evaluation of positive plasma samples. J Thromb Haemost 2007; 5: 925-30.
12. de Groot PG, Lutters B, Derksen RHWM, Lisman T, Meijers JCM, Rosendaal FR. Lupus anticoagulants and the risk of a first episode of deep venous thrombosis. J Thromb Haemost 2005; 3: 1993-7.
13. 2-glycoprotein I activity. Thromb Res 2007; 120: 127-33.
14. Piette JC, Cacoub MD. Antiphospholipid syndrome in the elderly: caution. Circulation 1998; 97: 2195-6.
15. Rapizzi E, Ruffatti A, Tonello M, Piccoli A, Calligaro A, Sfriso P, et al. Correction for age of anticardiolipin antibodies cut-off points. J Clin Lab Anal 2000; 14: 87-90.
16. 2-glycoprotein I measurement. Thromb Haemost 2002; 88: 66-73.
17. Pengo V, Biasiolo A. The risk of overdiagnosis of antiphospholipid antibody syndrome. Thromb Haemost 2001; 86: 933.
18. Pengo V. Communication, 48th Annual SSC meeting, Boston, MA, USA, July 18, 2002. See annual SSC reports at the ISTH website: http://www.med.unc.edu/isth
19. 2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant. J Thromb Haemost 2005; 3: 1160-5.
20. 2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-906.
21. 2-glycoprotein-I antibodies: a marker of antiphospholipid syndrome? Lupus 1995; 4: 122-30.
22. 2-Glycoprotein-I antibodies detection and association with thrombosis. Br J Haematol 1995; 89: 397-402.
23. 2-glycoprotein I antibodies in patients with thrombosis. Scand J Clin Lab 2003; 63: 11-8.
24. 2-glycoprotein I in the assessment of antiphospholipid syndrome. Blood Coag Fibrinolysis 2003; 14: 1-2.
25. Ruffatti A, Tonello M, Del Ross T, Cavazzana A, Grava C, Noventa F, et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost 2006; 96: 337-41.
26. Ruffatti A, Marson P, Pengo V, Favaro M, Tonello M, Bortolati M, et al. Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature. Autoimmun Rev 2007; 6: 196-202.